CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-25 | JONES STEVEN C Executive VP of Finance | Grant or award · Stock Option | +10,000 | $7.27 | $73K | 10,000 |
| 2017-05-25 | JONES STEVEN C Executive VP of Finance | Grant or award · Restricted Stock | +8,667 | 8,667 | ||
| 2017-05-25 | Johnson Kevin C Director | Grant or award · Stock Option (Right to Buy) | +10,000 | $7.27 | $73K | 10,000 |
| 2017-05-25 | Johnson Kevin C Director | Grant or award · Restricted Stock | +8,667 | 8,667 | ||
| 2017-05-25 | HANNAH ALISON L. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | $7.27 | $73K | 10,000 |
| 2017-05-25 | HANNAH ALISON L. Director | Grant or award · Restricted Stock | +8,667 | 8,667 | ||
| 2017-05-25 | SHOVLIN ROBERT J. President, Clinical Services | Grant or award · Restricted Stock | +50,000 | 50,000 | ||
| 2017-05-25 | VAN OORT DOUGLAS M Chairman and CEO | Grant or award · Restricted Stock | +197,042 | 197,042 | ||
| 2017-05-25 | CARDOZA GEORGE Chief Financial Officer | Grant or award · Restricted Stock | +25,000 | 25,000 | ||
| 2017-05-25 | BALLIET JENNIFER VP and Chief Culture Officer | Grant or award · Restricted Stock | +20,000 | 20,000 | ||
| 2017-05-25 | ALBITAR MAHER Chief Medical Officer | Grant or award · Restricted Stock | +20,000 | 20,000 | ||
| 2017-04-28 | BRODIE STEVEN G. Vice President of Operations | Grant or award · Stock Option (Right to Buy) | +50,000 | $7.52 | $376K | 50,000 |
| 2017-04-28 | VAN OORT DOUGLAS M Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +500,000 | $7.52 | $3.8M | 500,000 |
| 2017-04-28 | ALBITAR MAHER Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | $7.52 | $1.5M | 200,000 |
| 2017-04-28 | SHOVLIN ROBERT J. President, Clinical Services | Grant or award · Stock Option (Right to Buy) | +200,000 | $7.52 | $1.5M | 200,000 |
| 2017-04-28 | BALLIET JENNIFER VP and Chief Culture Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | $7.52 | $451K | 60,000 |
| 2017-04-28 | CARDOZA GEORGE Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | $7.52 | $1.5M | 200,000 |
| 2017-04-28 | ROSS STEVEN A CIO | Grant or award · Stock Option (Right to Buy) | +65,000 | $7.52 | $489K | 65,000 |
| 2017-03-27 | BRODIE STEVEN G. President, Pharma Services | Option exercise | +10,000 | $3.76 | $38K | 25,953 |
| 2017-03-27 | BRODIE STEVEN G. President, Pharma Services | Option exercise · Stock Option | −10,000 | $3.76 | $38K | 0 |
Page 50 of 51 · 1,005 trades